Stay updated with breaking news from Complement Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Copyright BusinessAMBE 08.07 - Gimv invests in Complement Therapeutics Investment group participates in a EUR 72 million financing round of Complement Therapeutics to finance the further... | April 17, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Press release content from Business Wire. The AP news staff was not involved in its creation.
CANbridge CAN106 Phase 1 Data Presented at the European Hematology Association 2022 Congress
Rapid and potent C5 inhibition achieved with complete and sustained blockage of complement by a single dose of CAN106 Data to be presented at the 14th International Conference on Complement